Literature DB >> 16465544

The tumor specific cytotoxicity of dihydronitidine from Toddalia asiatica Lam.

Hironori Iwasaki1, Hirosuke Oku, Ryo Takara, Hanako Miyahira, Kaoru Hanashiro, Yasuhiko Yoshida, Yasuhiro Kamada, Tetsuya Toyokawa, Kensaku Takara, Masashi Inafuku.   

Abstract

PURPOSE: In recent years, a number of reports have shown the anticancer activity of plant extracts and phytoalkaloid.
METHODS: We have evaluated the cytotoxicity profiles of 157 extracts prepared from dietary or medical plants growing in the Okinawa island, using 10 different cell lines. In vitro cytotoxicity screening indicated the presence of a highly selective cytotoxic compound in the extract of Toddalia asiatica Lam. The known alkaloid (1,3)benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-(dihydronitidine) was identified as an active material from this plant. This alkaloid had highly specific cytotoxicity to human lung adenocarcinoma (A549) cells.
RESULTS: The results of the fluorescence activated cell sorter (FACS) analysis and the measurement of caspase-3 activity showed that dihydronitidine induced specific apoptotic cell death in A549 cells. Gene expression analysis in the apoptotic cells found that dihydronitidine variously regulated the cell cycle related genes (CDK2 and CCNE), and up-regulated the cell death related genes specifically in tumor cells. Thus dihydronitidine manifested its characteristics in the tumor selective cytotoxicity, contrasting with the case of a known anticancer agent camptothecin (CPT). Microscopic observation further revealed the specific accumulation of dihydronitidine within the cytosolic organelle, but not in the nuclei of adenocarcinoma. No accumulation was observed with CPT in all cell lines.
CONCLUSION: The data suggested that dihydronitidine toxicity targeted a particular intracellular organelle in the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465544     DOI: 10.1007/s00280-005-0183-4

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

1.  Medicinal plants used in managing diseases of the respiratory system among the Luo community: an appraisal of Kisumu East Sub-County, Kenya.

Authors:  James Kiamba Mailu; Joseph Mwanzia Nguta; James Mucunu Mbaria; Mitchel Otieno Okumu
Journal:  Chin Med       Date:  2020-09-03       Impact factor: 5.455

2.  Bioassay-Guided Isolation of Cytotoxic Cycloartane Triterpenoid Glycosides from the Traditionally Used Medicinal Plant Leea indica.

Authors:  Yau Hsiung Wong; Habsah Abdul Kadir; Sui Kiong Ling
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-29       Impact factor: 2.629

3.  Multiple shoot regeneration and effect of sugars on growth and nitidine accumulation in shoot cultures of Toddalia asiatica.

Authors:  Chinthala Praveena; Ciddi Veeresham
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

4.  Molecular Docking and Molecular Dynamics to Identify a Novel Human Immunodeficiency Virus Inhibitor from Alkaloids of Toddalia asiatica.

Authors:  R Priya; Rajendrarao Sumitha; C George Priya Doss; C Rajasekaran; S Babu; R Seenivasan; R Siva
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

5.  Tumor-Selective Cytotoxicity of Nitidine Results from Its Rapid Accumulation into Mitochondria.

Authors:  Hironori Iwasaki; Masashi Inafuku; Naoyuki Taira; Seikoh Saito; Hirosuke Oku
Journal:  Biomed Res Int       Date:  2017-04-26       Impact factor: 3.411

6.  Cell Cycle Arrest and Apoptosis in HT-29 Cells Induced by Dichloromethane Fraction From Toddalia asiatica (L.) Lam.

Authors:  Xun Li; Zidong Qiu; Qinghao Jin; Guilin Chen; Mingquan Guo
Journal:  Front Pharmacol       Date:  2018-06-12       Impact factor: 5.810

7.  New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules.

Authors:  Yu-Ru Lee; Dah-Shyong Yu; Ya-Chun Liang; Kuo-Feng Huang; Shih-Jie Chou; Tsung-Chih Chen; Chia-Chung Lee; Chun-Liang Chen; Shih-Hwa Chiou; Hsu-Shan Huang
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.